Skip to main content
Livermore
Livermore
ZHEN

SkyOak Wealth, LLC

SEC CIK
0001800379
Latest filing
Jul 30, 2026

LCTX holding history

Lineage Cell Therapeutics, Inc. in every 13F filed by SkyOak Wealth, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LCTX overviewAll 13F holders of LCTXFull Q2 2026 holdings

Shares (Q2 2026)
15,000
Value
$19.6K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of LCTX by SkyOak Wealth, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202615,000$19.6K<0.1%00.0%UnchangedHolders
Q1 202615,000$23.7K<0.1%00.0%UnchangedHolders
Q4 202515,000$25.1K<0.1%00.0%UnchangedHolders
Q3 202515,000$25.4K<0.1%00.0%UnchangedHolders
Q2 202515,000$13.6K<0.1%00.0%UnchangedHolders
Q1 202515,000$6.77K<0.1%00.0%UnchangedHolders
Q4 202415,000$7.54K<0.1%00.0%UnchangedHolders
Q3 202415,000$13.6K<0.1%00.0%UnchangedHolders
Q2 202415,000$15.0K<0.1%00.0%UnchangedHolders
Q1 202415,000$22.2K<0.1%00.0%UnchangedHolders
Q4 202315,000$16.4K<0.1%00.0%UnchangedHolders
Q3 202315,000$17.7K<0.1%00.0%UnchangedHolders
Q2 202315,000$21.1K<0.1%00.0%UnchangedHolders
Q1 202315,000$22.5K<0.1%00.0%UnchangedHolders
Q4 202215,000$17.6K<0.1%00.0%UnchangedHolders
Q3 202215,000$17.0K<0.1%00.0%UnchangedHolders
Q2 202215,000$24.0K<0.1%00.0%UnchangedHolders
Q1 202215,000$23.0K<0.1%00.0%UnchangedHolders
Q4 202115,000$37.0K<0.1%00.0%UnchangedHolders
Q3 202115,000$38.0K<0.1%00.0%UnchangedHolders
Q2 202115,000$43.0K<0.1%00.0%UnchangedHolders
Q1 202115,000$40.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.